XTX Topco’s IN8bio INAB Stock Holding History

XTX Topco’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,433	Closed	-$18.4K	–	4410
2026 Q1	$18.4K	Sell	12,433 -4,610	-27%	-$8.91K	﹤0.01%	3569
2025 Q4	$39.9K	Buy	17,043 +4,551	+36%	+$8.65K	﹤0.01%	2888
2025 Q3	$27.1K	Buy	+12,492	New	+$27.5K	﹤0.01%	2276
2025 Q2	–	Sell	-2,324	Closed	-$11.6K	–	2739
2025 Q1	$11.6K	Buy	2,324 +911	+64%	+$7.27K	﹤0.01%	2234
2024 Q4	$10.9K	Buy	+1,413	New	+$12.4K	﹤0.01%	2135

Other funds holding INAB

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

XTX Topco's INAB Position: Q2 2026 in Review

XTX Topco sold out of IN8bio (INAB) in Q2 2026, closing a stake of 12,433 shares — an estimated $18.4K sold.

XTX Topco first reported a position in INAB in Q4 2024 and held it in 5 quarters. The position peaked at $39.9K in Q4 2025. 21 funds tracked by Wall St. Rank hold INAB as of Q2 2026.

XTX Topco reported no remaining IN8bio position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 12,433 IN8bio shares in Q2 2026, an estimated $18.4K.
XTX Topco first reported a position in IN8bio in Q4 2024 and held it in 5 quarters.
XTX Topco's IN8bio position peaked at $39.9K in Q4 2025.
21 funds tracked by Wall St. Rank held IN8bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.